MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications:

Similar documents
MedStar Health considers Cough Assist Devices medically necessary for the following indications:

MedStar Health considers External Counterpulsation Therapy (ECP) medically necessary for the following indications:

Premier Health Plan considers Oral Appliances for Obstructive Sleep Apnea (OSA) medically necessary for the following indications:

MP.094.MH Transcutaneous Electrical Nerve Stimulators

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.010.MH Last Review Date: 05/11/2017 Effective Date: 07/01/2017

Home Pulse Oximetry for Infants and Children

Premier Health Plan considers Iontophoresis for Musculoskeletal Conditions medically necessary for the following indications:

MedStar Health considers Septoplasty-Rhinoplasty medically necessary for the following indications:

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications:

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.103.MH Last Review Date: 11/08/2018 Effective Date: 02/01/2019

MP.090.MH Nerve Block, Paravertebral, Facet Joint, and SI Injections

Clinical Policy: Oxygen Therapy in the Home Reference Number: CP.MP.485

Blepharoptosis repair is covered as functional/reconstructive surgery to correct: Visual impairment due to droop or displacement of the upper lid.

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.017.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2016

Clinical Policy: Multiple Sleep Latency Testing

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

Clinical Policy: DNA Analysis of Stool to Screen for Colorectal Cancer

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL

Airway Clearance Devices

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

Clinical Policy: Fecal Calprotectin Assay Reference Number: CP.MP.135

Clinical Policy: Digital EEG Spike Analysis

Clinical Policy: Implantable Miniature Telescope for Age Related Macular Degeneration Reference Number: CP.MP.517

Oxygen and Oxygen Equipment

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

Oxygen and Oxygen Equipment

Itamar Medical 2016 Reimbursement Coding Guide

MP.098.MH Trigger Point and Transforaminal Epidural Injections

POLICIES AND PROCEDURE MANUAL

Is Hypoxia common despite oxygen treatment in the Acute Medical ward?

Clinical Policy: Total Artificial Heart Reference Number: CP.MP.127

Clinical Policy: Cochlear Implant Replacements Reference Number: CP.MP.14

Oxygen Saturation Monitors & Pulse Oximetry. D. J. McMahon rev cewood

Clinical Policy: Fractional Exhaled Nitric Oxide Reference Number: CP.MP.103

Clinical Policy: Digital Breast Tomosynthesis Reference Number: CP.MP.90

CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

Clinical Policy: Homocysteine Testing Reference Number: CP.MP.121

Clinical Policy: Cochlear Implant Replacements

Clinical Policy: Trigger Point Injections for Pain Management

Clinical Policy: Iron Sucrose (Venofer) Reference Number: CP.PHAR.167

Appendix E Choose the sign or symptom that best indicates severe respiratory distress.

SmartMonitor Helpful for Filing

Clinical Policy: Ambulatory Electroencephalography Reference Number: CP.MP.96

ALCO Regulations. Protocol pg. 47

Clinical Policy: Ferric Carboxymaltose (Injectafer) Reference Number: CP.PHAR.234

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Clinical Policy: Growing Rods Spinal Surgery Reference Number: CP.MP.354

Clinical Policy: Atezolizumab (Tecentriq) Reference Number: CP.PHAR.235 Effective Date: 06/16 Last Review Date: 05/17

Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145

See Important Reminder at the end of this policy for important regulatory and legal information.

Policy Specific Section: October 1, 2010 January 21, 2013

Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18

DECISION AND ORDER. After due notice, a telephone hearing was held on. , Medical Director, also testified as a witness for the MHP.

Clinical Policy: Inhaled Nitric Oxide Reference Number: CP.MP.87

Clinical Policy: Essure Removal Reference Number: CP.MP.131

Home Cardiorespiratory Monitoring. Description. Section: Durable Medical Equipment Effective Date: April 15, 2017

MEDICAL POLICY SUBJECT: PULMONARY REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

RESPIRATORY ASSIST DEVICE E0471

Capnography 101. James A Temple BA, NRP, CCP

Clinical Policy: Ferumoxytol (Feraheme) Reference Number: CP.PHAR.165

Clinical Policy: Fluticasone/Salmeterol (Advair Diskus, Advair HFA) Reference Number: CP.PMN.31 Effective Date: 08/16 Last Review Date: 08/17

See Important Reminder at the end of this policy for important regulatory and legal information.

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL

Clinical Policy: Thryoid Hormones and Insulin Testing in Pediatrics Reference Number: CP.MP.154

Sleep Apnea: Diagnosis and Treatment

National Medical Policy

Clinical Policy: Gastric Electrical Stimulation

Coding for Sleep Disorders Jennifer Rose V. Molano, MD

RESPIRATORY ASSIST DEVICE E0470

RESPIRATORY ASSIST DEVICE E0471

Clinical Policy: Helicobacter Pylori Serology Testing Reference Number: CP.MP.153

Medicare C/D Medical Coverage Policy. Respiratory Assist Devices for Obstructive Sleep Apnea and Breathing Related Sleep Disorders

Clinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132

Clinical Policy: Laser Therapy for Skin Conditions Reference Number: CP.MP.123 Last Review Date: 08/17

Clinical Policy: Implantable Hormone Pellets Reference Number: CA.CP.MP.507

Helpful hints for filing

Clinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156

MP.015.MH Compression Stockings and Garments

See Important Reminder at the end of this policy for important regulatory and legal information.

Respiratory Assist Device E0470:

Clinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy: Eribulin Mesylate (Halaven) Reference Number: CP.PHAR.318

Asthma Coding Fact Sheet for Primary Care Pediatricians

Inspire Medical Systems. Physician Billing Guide

Sympathetic Electrical Stimulation Therapy for Chronic Pain

Anthem Midwest Clinical Claims Edit

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19

(Non)-invasive ventilation: transition from PICU to home. Christian Dohna-Schwake

Transcription:

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.006.MH Continuous Home Pulse Oximetry This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst PPO MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications: 1. Continuous pulse oximetry performed in the home is covered only when any of the following indications is present: Patients on prolonged home mechanical ventilation when the ventilator does not have a built in pulse oximeter, or Home Care patients with tracheostomies, or Premature or infants under one year with bronchopulmonary dysplasia AND 2. Continuous pulse oximetry performed in the home is covered only when all of the following indications are present: The recipient would otherwise require hospitalization solely for the purpose of continuous monitoring, The results are reliable in that setting, The patient s record documents that the oximeter is preset and self-sealed and cannot be adjusted by the patient, The device is able to provide a printout which documents an adequate number of sampling hours (a minimum of four hours should be recorded), percent of oxygen saturation and an aggregate of the results (this information must be available if requested), and A trained caregiver is available to respond to changes in the oxygen saturation. Limitations Continuous pulse oximetry performed in the home is not covered for any of the following indications: For routine monitoring of an individual with oxygen (not medically appropriate)

As part of an individual s asthma management (not medically appropriate) For management of chronic obstructive pulmonary disease (COPD) For management of transient hypoxemic events For screening or management of a sleep disorder (e.g., sleep apnea) Pulse oximeters can be used just intermittently for a spot check (digital pulse oximeter) or used continuously which is mainly performed in the inpatient care setting. The oximetry device used is subject to the Food and Drug Administration (FDA) regulations/approval. A complete list may be obtained by inserting product code DQA into the 510(k) approvals database. Background Pulse oximetry measures oxygen saturation by utilizing selected wavelengths of light to noninvasively determine the saturation of oxyhemoglobin. The oximeter passes red light through the fingertip or earlobe; the amount of light that is absorbed reflects how much oxygen is in the blood. This is done by measuring light absorption of oxygenated hemoglobin and total hemoglobin in arterial blood. Pulse oximetry is considered a safe procedure but the device does have limitations that can lead to inaccurate measurements, including: motion artifact, abnormal hemoglobins, skin pigmentation, low perfusion states, nail polish and ambient light. These limitations may lead to a false negative and potentially inappropriate treatment of the individual. Codes: HCPCS Codes Code E0445 A4606 Description Not Covered ICD-9 Codes Oximeter device for measuring blood oxygen levels noninvasively Oxygen probe for use with oximeter device,replacement 327.23 Obstructive sleep apnea (adult)(pediatric) 327.24 Idiopathic sleep related non-obstructive alveolar hypoventilation 327.26 Sleep related hypoventilation/hypoxemia in conditions classifiable elsewhere 493.90-493.92 Asthma Page 2 of 5

496 Chronic airway obstruction, not elsewhere classified (NEC) 780.50-780.59 Sleep disturbances V81.4 Screening for other and unspecified respiratory conditions Not Covered ICD-10 Codes G47.33 Obstructive sleep apnea (adult) (pediatric) G47.34 Idiopathic sleep related non-obstructive alveolar hypoventilation G47.36 Sleep related hypoventilation in conditions classified elsewhere G47.8 Other sleep disorders G47.9 Sleep disorder, unspecified J44.9 Chronic airway obstruction, not elsewhere classified (NEC) J45.909-J45.998 Asthma Z13.83 Encounter for screening for respiratory disorder NEC Variations Medicare Advantage Products: Continuous home pulse oximetry will be denied as not a covered benefit. Page 3 of 5

References 1. American Association Respiratory Care. AARC clinical practice guidelines. Pulse oximetry. Respir Care. 1992 Aug ; 37(8): 891-897. http://www.rcjournal.com/cpgs/pulsecpg.html 2. Centers for Medicare and Medicaid Services (CMS). National Coverage Determination (NCD) for Home Use of Oxygen (240.2). Effective date 10/27/1993. https://www.cms.gov/medicare-coverage-database/details/ncddetails.aspx?ncdid=169&ncdver=1&docid=240.2&bc=gaaaaagaaaaaaa%3d %3d& 3. Centers for Medicare and Medicaid Services (CMS). Local Coverage Determination (LCD). Oxygen and Oxygen Equipment. L33797 effective 10/1/2015. https://www.cms.gov/medicare-coverage-database/details/lcddetails.aspx?lcdid=33797&contrid=137&ver=4&contrver=1&date=&docid=l3 3797&bc=iAAAAAgAAAAAAA%3d%3d& 4. Centers for Medicare and Medicaid Services (CMS). Local Coverage Determination (LCD). Oximetry Services. L35434 effective 10/1/2015. 5. Church, G. California Thoracic Society Position Paper: Guidelines for the Use of Home Pulse Oximetry in Infants and Children. 2012. https://www.calthoracic.org/sites/default/files/pdfs/ctspositionpaper_guidelines %20for%20the%20Use%20of%20Home%20Pulse%20Oximetry%20InfantsChildr en_2012.pdf 6. Hayes Health Technology Brief. Continuous Pulse Oximetry for Managing Home Oxygen Therapy in Adults. Annual Review January 21, 2010. 7. McCulloh R, Koster M, Ralston S, et al. Use of Intermittent vs. Continuous Pulse Oximetry for Nonhypoxemic Infants and Young Children Hospitalized for Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr. 2015 Oct 1; 169 (1): 898-904. http://www.ncbi.nlm.nih.gov/pubmed/26322819 Disclaimer: MedStar Health medical payment and prior authorization policies do not constitute medical advice and are not intended to govern or otherwise influence the practice of medicine. The policies constitute only the reimbursement and coverage guidelines of MedStar Health and its affiliated managed care entities. Coverage for services varies for individual members in accordance with the terms and conditions of applicable Certificates of Coverage, Summary Plan Descriptions, or contracts with governing regulatory agencies. MedStar Health reserves the right to review and update the medical payment and prior authorization guidelines in its sole discretion. Notice of such changes, if necessary, shall be provided in accordance with the terms and conditions of provider agreements and any applicable laws or regulations. Page 4 of 5

These policies are the proprietary information of Evolent Health. Any sale, copying, or dissemination of said policies is prohibited. Page 5 of 5